Guided Therapeutics Announces Pricing of $3.8 Million Public Offering
MarketWatch … stock, and warrants to purchase shares of its common stock, for gross proceeds to the Company (including non-cash extinguishment of debt) of approximately $3.8 million. The shares and warrants are being offered at a combined price of $0.225 per share. |